Stock listing
A1J84E Stock Price, News, Filings & Events — Abbvie Inc.
Selected listing: A1J84E · LSX · EUR · DE
This page tracks Abbvie Inc.'s A1J84E:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1J84E:LSX. A1J84E:LSX is the stock-level entry point for investors researching Abbvie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abbvie Inc. (ticker: ABBV) is a publicly traded company based in the United States, with a market capitalization of approximately $458.24 billion. The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.

- Ticker
- A1J84E:LSX
- Asset type
- Stock
- Market cap
- $440.83B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Abbvie Inc. A1J84E:LSX stock context
This page tracks Abbvie Inc.'s A1J84E:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1J84E:LSX. A1J84E:LSX is the stock-level entry point for investors researching Abbvie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abbvie Inc. (ticker: ABBV) is a publicly traded company based in the United States, with a market capitalization of approximately $458.24 billion. The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.
Research Abbvie Inc.
Abbvie Inc. investor report
Review AI stock analysis and investor report context for A1J84E:LSX.
Abbvie Inc. company profile
View the public company page for Abbvie Inc. on 6ix.
Abbvie Inc. news
Read company news and market updates connected to Abbvie Inc..
Abbvie Inc. investor events
Find investor webinars, events, and replay context for Abbvie Inc..
Alternate listings
ABBV:NYSE
US · USD
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
4AB:GETTEX
DE · EUR
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV:BCBA
AR · ARS
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV19:SET
TH · THB
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
4AB:TRADEGATE
DE · EUR
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV:TSX
CA · CAD
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
4AB:XETR
DE · EUR
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV:NEO
CA · CAD
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV34:BMFBOVESPA
BR · BRL
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV80:SET
TH · THB
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
ABBV:BMV
MX · MXN
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.
1ABBV:MIL
IT · EUR
Alternate listing for Abbvie Inc.; the primary context on this page is A1J84E:LSX.